Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Cash generated from core business operations
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-52.26M | -6.5% |
| 2024 | $-49.06M | -59.9% |
| 2023 | $-30.68M | -14.7% |
| 2022 | $-26.75M | +62.3% |
| 2021 | $-70.89M | -74.9% |
| 2020 | $-40.54M | -111.9% |
| 2019 | $-19.13M | -511.7% |
| 2018 | $-3.13M | -125.0% |
| 2017 | $12.52M | +185.9% |
| 2016 | $-14.57M | - |